The chickenpox vaccine has been safely used for decades and is already part of the routine vaccine schedules in several countries, including the United States, Canada, Australia and Germany.
The vaccine will help reduce cases of chickenpox and protect children from serious complications that can cause hospitalisation, such as bacterial infections like strep A, brain and lung inflammation and stroke. Vaccinating children against chickenpox will help to avoid days off school and nursery for children and time off work for parents needing to look after them.
The government’s decision to roll out the MMRV vaccine in January is based on expert scientific advice from the Joint Committee on Vaccination and Immunisation (JCVI), following research showing the significant impact of severe cases of chickenpox on children’s health, hospital admissions and associated costs.
Private vaccinations for chickenpox at pharmacies and clinics currently cost around £150 for a full course of two doses. This rollout will mean the vaccination will be available free of charge on the NHS to eligible children.
The eligibility criteria for children will be set out over the coming months in clinical guidance covering which age groups will get the MMRV vaccine and when, to ensure the most effective protection for children.
As with other childhood immunisations, parents will be contacted by their GP surgery to arrange an appointment if their child is eligible.